Total and Subtypes of Dietary Fat Intake and Its Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiovascular Risk
- PMID: 31261967
- PMCID: PMC6682917
- DOI: 10.3390/nu11071493
Total and Subtypes of Dietary Fat Intake and Its Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiovascular Risk
Abstract
Background: The effect of dietary fat intake on the metabolic syndrome (MetS) and in turn on cardiovascular disease (CVD) remains unclear in individuals at high CVD risk. Objective: To assess the association between fat intake and MetS components in an adult Mediterranean population at high CVD risk. Design: Baseline assessment of nutritional adequacy in participants (n = 6560, men and women, 55-75 years old, with overweight/obesity and MetS) in the PREvención con DIeta MEDiterránea (PREDIMED)-Plus randomized trial. Methods: Assessment of fat intake (total fat, monounsatured fatty acids: MUFA, polyunsaturated fatty acids: PUFA, saturated fatty acids: SFA, trans-fatty acids: trans-FA, linoleic acid, α-linolenic acid, and ω-3 FA) using a validated food frequency questionnaire, and diet quality using 17-item Mediterranean dietary questionnaire and fat quality index (FQI). Results: Participants in the highest quintile of total dietary fat intake showed lower intake of energy, carbohydrates, protein and fiber, but higher intake of PUFA, MUFA, SFA, TFA, LA, ALA and ω-3 FA. Differences in MetS components were found according to fat intake. Odds (5th vs. 1st quintile): hyperglycemia: 1.3-1.6 times higher for total fat, MUFA, SFA and ω-3 FA intake; low high-density lipoprotein cholesterol (HDL-c): 1.2 higher for LA; hypertriglyceridemia: 0.7 lower for SFA and ω-3 FA intake. Conclusions: Dietary fats played different role on MetS components of high CVD risk patients. Dietary fat intake was associated with higher risk of hyperglycemia.
Keywords: Mediterranean diet; cardiovascular disease risk; dietary fat; fat intake; fatty acids.
Conflict of interest statement
J.S.-S. reports serving on the board of and receiving grant support through his institution from International Nut and Dried Fruit Council; receiving consulting personal fees from Danone, Font Vella Lanjarón, Nuts for Life, and Eroski; and receiving grant support through his institution from Nut and Dried Fruit Foundation and Eroski. ER reports grants, non-financial support, and other fees from California Walnut Commission and Alexion; personal fees and non-financial support from Merck, Sharp & Dohme; personal fees, non-financial support and other fees from Aegerion, and Ferrer International; grants and personal fees from Sanofi Aventis; grants from Amgen and Pfizer and; personal fees from Akcea, outside of the submitted work. XP reports serving on the board of and receiving consulting personal fees from Sanofi Aventis, Amgen, and Abbott laboratories; receiving lecture personal fees from Esteve, Lacer and Rubio laboratories.MD-R reports receiving grants from the Diputación Provincial de Jaén and the Caja Rural de Jaén. LD reports grants from Fundación Cerveza y Salud. All other authors declare no competing interest.
References
-
- RTI International Projections of Cardiovascular Disease Prevalence and Costs: 2015–2035. [(accessed on 10 December 2018)]; Available online: https://healthmetrics.heart.org/wp-content/uploads/2017/10/Projections-o....
-
- Riaz H., Khan M.S., Siddiqi T.J., Usman M.S., Shah N., Goyal A., Khan S.S., Mookadam F., Krasuski R.A., Ahmed H. Association Between Obesity and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Mendelian Randomization Studies. JAMA Netw. Open. 2018;1:e183788. doi: 10.1001/jamanetworkopen.2018.3788. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI1/Instituto de Salud Carlos III/International
- CIBEROBN/Instituto de Salud Carlos III/International
- Advanced Research Grant 2013-2018; 340918/ERC_/European Research Council/International
- 2013ACUP00194/Recercaixa/International
- PI0458/2013; PS0358/2016; PI0137/2018/Consejería de Salud de la Junta de Andalucía/International
- PROMETEO/2017/017/Generalitat Valenciana/International
- no ref./SEMERGEN grant/International
- no ref./FEDER funds/International
- 201302/ISCIII. International Nut & Dried Fruit Council - FESNAD/International
- 35/2011/Balearic Islands Gov/International
- CA16112/European Cooperation in Science and Technology/International
- 201630.10/Fundació La Marató TV3/International